-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. The company's subsidiary Suzhou Shengdia Biomedical Co., Ltd. has received approval from the State Drug Administration (hereinafter referred to as the “State Drug Administration”) to issue a “Drug Clinical Trial Approval Notice” for SHR-3079 injections and will conduct clinical trials in the near future.

Zhitongcaijing·07/13/2026 12:41:08
Listen to the news
Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. The company's subsidiary Suzhou Shengdia Biomedical Co., Ltd. has received approval from the State Drug Administration (hereinafter referred to as the “State Drug Administration”) to issue a “Drug Clinical Trial Approval Notice” for SHR-3079 injections and will conduct clinical trials in the near future.